PHUONG LUU: Open Payments
NPI 1649257353 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,086 in 32 payments from 9 companies in 2025. Trend: 2023 $910 · 2024 $1,465 · 2025 $1,086
Food & beverage: $1,086
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $284 |
| Janssen Scientific Affairs, LLC | 2 | $261 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $131 |
| GENZYME CORPORATION | 3 | $105 |
| Regeneron Healthcare Solutions, Inc. | 4 | $90 |
| Mirum Pharmaceuticals, Inc. | 4 | $76 |
| Alcresta Therapeutics, Inc. | 3 | $72 |
| IntraBio Inc | 2 | $46 |
| Eton Pharmaceuticals, Inc. | 1 | $20 |
Products named: TREMFYA, DUPIXENT, RINVOQ, SKYRIZI, GATTEX, Livmarli, RELIZORB, AQNEURSA.
Industry payments across TX — which companies pay providers there.
